Navigation Links
Stanford blood scanner detects even faint indicators of cancer
Date:12/2/2008

A team led by Stanford researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival.

The system based on MagArray biodetection chips can find cancer-associated proteins in a blood serum sample in less than an hour, and with much greater sensitivity than existing commercial devices. In fact, the device, which uses magnetic nanotechnology to spot the cancer proteins, is tens to hundreds of times more sensitive, meaning the proteins can be found while there are relatively few of them in the bloodstream. The researchers reported their results in the Dec. 1 online edition of the Proceedings of the National Academy of Sciences (PNAS).

"This is essentially a proof-of-concept study showing that now we have a chip and a reader that can find multiple biomarkers in a sample at a concentration much lower than the standard that is commercially available," said Shan Wang, a Stanford professor of materials science and of electrical engineering.

Wang is optimistic that the technology will someday save lives by detecting cancer early or by helping doctors select more effective therapy. "The earlier you can detect a cancer, the better chance you have to kill it," he said. "This could be especially helpful for lung cancer, ovarian cancer and pancreatic cancer, because those cancers are hidden in the body."

Wang is a senior author of the paper, along with Stanford biochemistry and genetics Professor Ronald W. Davis of the Stanford Genome Technology Center, and UC Santa Cruz biomolecular engineering Professor Nader Pourmand.

The detector is able to detect many different kinds of proteins at the same time, which is important for two reasons, Wang said. First, researchers are still uncertain which cancer biomarkers are the best diagnostic indicators. Secondly, det
'/>"/>

Contact: David Orenstein
davidjo@stanford.edu
650-736-2245
Stanford University
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Stanford/Packard study shows no benefit from drug widely used to prevent premature births
2. Stanfords Precourt Institute for Energy Efficiency awards new round of faculty research grants
3. Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows
4. Asian-white couples face distinct pregnancy risks, Stanford/Packard
5. The Leukemia & Lymphoma Society Awards Major Grant to Stanford Researcher
6. Stanford University Rises to Top of 2008 Trojan(R) Sexual Health Report Card
7. New leukemia signal could point way to better treatment, Stanford researchers find
8. Risk of breast cancer mutations underestimated for Asian women, Stanford study shows
9. New approach, old drug show promise against hepatitis C, Stanford research shows
10. Early trigger for type-1 diabetes found in mice, Stanford scientists report
11. New method to overcome multiple drug resistant diseases developed by Stanford researchers

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stanford blood scanner detects even faint indicators of cancer
Stanford blood scanner detects even faint indicators of cancer
(Date:11/27/2009)... XenaCare Holdings has announced that it has b...on, one of the largest nonprofit organizations ded...cation. , Delray Beach, F...Inc. (OTCBB: XCHO), a company specializing in the ...thcare products, has announced today that is has b...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allrecipe...d-high Thanksgiving traffic numbers, with more tha..., providing a clear picture of what was served on ...Thanksgiving meal in 2009 weighed in at 2,225 calo...ear,s feast. According to the Allrecipes site, Sw...
(Date:11/27/2009)... Specialist manufacturers who use medical load...illions of dollars by bringing in technology partn... numbers of pro-active medical manufacturers are c... stage of their projects, ensuring that progress w...s or potentially outdated technology. , ...
(Date:11/26/2009)...ON, N.J., Nov. 27 The diabetes pop...er the next 25 years and annual medical spending o... from $113 billion today, according to a study pub...The National Changing Diabetes ® Program (NC...nalysis by a team from the University of Chicago. ...
(Date:11/26/2009)...g or too heavy can lead to strains or worse , ...e may be nothing wrong with stuffing your turkey f...same thing with your suitcase as you pack for holi...ed in 2008 in U.S. hospital emergency rooms, docto...for luggage-related injuries, such as muscle strai...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2
...event High Heel Hangover, SALEM, N.H., Dec. 3 Ev...ou feel after a day or night in heels. The dreaded...el hangover can be,eliminated from your life, with...t their bodies. Not only will your feet,ache, but ...
...euticals, Inc.,(Nasdaq: SGXP ) today announced th...ND) application to the U.S. Food and Drug Administ...developed, orally-bioavailable, small,molecule inh...008., "This IND submission is one quarter earlier...
... Partnerships with Centers of Influence, POWAY, C...), a leading provider of medical diagnostic imagin...pitals and imaging centers, today,announced the si...onths,ago of Digirad,s centers of influence busine...
...y 2008, TARRYTOWN, N.Y., Dec. 3 EpiCept Corporat...nnounced that it has,completed patient enrollment ... NP-1 cream. EpiCept NP-1 is a patented topical cr...europathies., (Logo: http://www.newscom.com/cgi-...
...illness and drug addiction so often go together" N...is may stem from a common cause: developmental cha...brain linked to fear, anxiety and other emotions. ...ociation (APA). , Dual diagnosis is common yet di...
...2 Forest,Laboratories, Inc. (NYSE: FRX ) and Myl...eived an approvable letter from the U.S. Food and ...rug Application (NDA) for,nebivolol (proposed bran...inspection of,a backup manufacturing facility in B...
Other Medicine News:Health News:High Heel Health 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 2Health News:SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor 3Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 2Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 3Health News:Digirad Corporation and The Methodist Hospital in Houston Sign Letter of Agreement 4Health News:Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy 2Health News:Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy 3Health News:Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy 4Health News:Mental illness and drug addiction may co-occur due to disturbance in part of the brain 2Health News:Mental illness and drug addiction may co-occur due to disturbance in part of the brain 3Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 2Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 3
(Date:11/25/2009)...wswire/ -- ChemoCentryx, Inc., announced today t...PROTECT-1 (the Prospective Randomized Oral Therapy...EN(TM) (CCX282-B) in patients with moderate-to-sev... with a favorable safety and tolerability profile....cacy in the reduction of disease severity as defin...
(Date:11/24/2009)...- ,, WHAT: Rom Houbens, a Belgian man thought...to accident, was actually fully conscious and awak...orning America segment. The DynaVox EyeMax was fe...h Locked-in Syndrome and other conditions can unlo...a -- Tuesday, November 24 available online at ...
(Date:11/24/2009)...re-FirstCall/ -- Quest Diagnostics Incorporated (N...nostic testing, information and services, announce... Piper Jaffray Healthcare Conference in New York C... December 2, 2009 at 9:30 a.m. Eastern Time. ,,...its 2009 guidance for revenue growth to approximat...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX 0401 28Perifosine 29 at the 51st Annual Meeting of the A 6163 1Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX 0401 28Perifosine 29 at the 51st Annual Meeting of the A 6163 2Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX 0401 28Perifosine 29 at the 51st Annual Meeting of the A 6163 3Natural Alternatives International Inc Announces Filing of Patent Infringement Lawsuit 6158 1Natural Alternatives International Inc Announces Filing of Patent Infringement Lawsuit 6158 2When seconds count 3A Interventional radiology treatment for pulmonary embolism saves lives 61137 1When seconds count 3A Interventional radiology treatment for pulmonary embolism saves lives 61137 2When seconds count 3A Interventional radiology treatment for pulmonary embolism saves lives 61137 3
...idiary of,Pharmexa A/S, presents selected data fro...enza Conference entitled, "Options for,the Control...a. The,data show that a "universal" vaccine design...otect transgenic mice against,lethal experimental ...e 21, 2007-Pharmexa-Epimmune, the,U.S.-based subsi...
...WIRE)--Jun 21, 2007,- The Institute for OneWorld H...y, today announced that Phase 3 research,related t...Injection (Paromomycin), was published in the curr...NEJM). This clinical trial shows,that the medicine...o curing visceral leishmaniasis (VL), the world,s ...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 2Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 3Research on New Treatment for Neglected Disease Published in The,New England Journal of Medicine 4
200 L Pipette Tip (RNase, DNase and pyrogen free)
MBP XLPFor Hard-to-Reach Places
MBP 300E Multi-Channel
Luteinizing hormone (LH) ELISA
Medicine Products: